FTO and melanoma: In melanoma, FTO can impair IFNγ-induced killing via augmenting CXCR4, PD-1 and SOX10 expression via repressing YTHDF2-mediated degradation and suppress response to anti-PD-1 blockade immunotherapy (Yang S. et al., 2019).